Rapid point-of-care molecular test for sars-COV-2 and influenza a/b

Ended Formula Grant Awarded Last action

Award ID
R43GH002392
Recipient
Awarding agency
Obligated
$1,102,828

Award facts

Assistance listing
93.354 Public Health Emergency Response: Cooperative Agreement for Emergency Response: Public Health Crisis Response
Completion date
Originally
Funding
  • $827,061.58 Federal
  • $275,766.00 Non-federal
Funding agency
Office of the Director Centers for Disease Control and Prevention, Department of Health and Human Services
Place of performance
Texas, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$118 $0
Amendment -$118 $0
Amendment $0 $0
Amendment $275,766 $0
Amendment $275,766 $275,766
Original award $275,766 $0

Quick answers

Who received award R43GH002392?

R43GH002392 was awarded to Ai Biosciences, Inc. by Office of Financial Resources (Centers for Disease Control and Prevention) on September 30, 2022.

How much is award R43GH002392 worth?

$1,102,828 has been obligated on R43GH002392: $827,062 in federal funding and $275,766 in non-federal funding.

Which agency awarded R43GH002392?

Office of Financial Resources (Centers for Disease Control and Prevention) awarded R43GH002392, with funding from Office of the Director (Centers for Disease Control and Prevention).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award